Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(0.14)
# 4,144
Out of 4,761 analysts
5
Total ratings
20%
Success rate
-25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics | Maintains: Overweight | $31 → $19 | $7.41 | +156.41% | 2 | Dec 19, 2024 | |
| XNCR Xencor | Initiates: Overweight | $37 | $15.74 | +135.07% | 1 | Dec 12, 2024 | |
| RCUS Arcus Biosciences | Initiates: Overweight | $29 | $11.07 | +161.97% | 1 | Oct 8, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Overweight | $34 | $20.02 | +69.83% | 1 | May 3, 2024 |
iTeos Therapeutics
Dec 19, 2024
Maintains: Overweight
Price Target: $31 → $19
Current: $7.41
Upside: +156.41%
Xencor
Dec 12, 2024
Initiates: Overweight
Price Target: $37
Current: $15.74
Upside: +135.07%
Arcus Biosciences
Oct 8, 2024
Initiates: Overweight
Price Target: $29
Current: $11.07
Upside: +161.97%
Kiniksa Pharmaceuticals International,
May 3, 2024
Initiates: Overweight
Price Target: $34
Current: $20.02
Upside: +69.83%